Digital Health Late Stage Investors & VC Firms
327 firms in this list, with a median first check of $1.1M. 99 of them lead rounds. Generated from verified public data and updated continuously.
Majuven
SingaporeSeed–Late Stage
4 people
Lotus Capital
CupertinoGrowth–Late Stage
1 person
Jumpstart Health Investors
NashvillePre-Seed–Late Stage
4 people
Healthcare Venture Partners, Llc
CharlestonSeries B–Late Stage
3 people
Montreux Equity Partners
San FranciscoGrowth–Late Stage$10M – $20M
Sangel Capital
ShenzhenSeed–Late Stage
Aescuvest
Frankfurt am MainSeed–Late Stage
1 person
West Capital
AlpineSeries A–Late Stage
3 people
MCI Capital
WarsawSeries B–Late Stage$27M – $108M
Cathay Health
San FranciscoSeed–Late Stage
1 person
Mother Ventures
New YorkSeed–Late Stage
2 people
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Gilmartin Capital LLC
LarkspurSeries A–Late Stage
2 people
Mayo Clinic Ventures
RochesterSeed–Late Stage
2 people
Analog Ventures
Mill ValleyPre-Seed–Late Stage
1 person
NJF Capital
LondonSeed–Late Stage
1 person
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
Frontier Path VC
LondonGrowth–Late Stage
1 person
Haibang Capital
HangzhouPre-Seed–Late Stage
1 person
HealthTrend Capital
BostonSeed–Late Stage
1 person
MedTech Entrepreneurs (MTE)
GräfelfingSeed–Late Stage
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
Related lists
Late Stage Investors & VC Firms (2864)Digital Health Investors & VC Firms (1179)Late Stage Investors & VC Firms in United States (1101)Digital Health Seed Investors & VC Firms (966)Digital Health Series A Investors & VC Firms (890)Late Stage Investors & VC Firms in Global (857)Healthtech Late Stage Investors & VC Firms (847)Enterprise Software Late Stage Investors & VC Firms (801)SaaS Late Stage Investors & VC Firms (784)Digital Health Investors & VC Firms in United States (692)
Data sourced from public filings and firms' own websites — see our methodology.


















